Altimmune Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ALT Nasdaq 2834 http://www.altimmune.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Altimmune Inc

Stock Performance Review on Alder Biopharma and Three Other Biotech Stocks - Jun 11th, 2018 5:10 am
U.S. hedge fund Hudson Bay to open London office - sources - Jun 5th, 2018 4:45 am
Does Altimmune Inc’s (NASDAQ:ALT) CEO Salary Reflect Performance? - May 24th, 2018 11:47 am
Gaithersburg biotech faces threat of stock delisting - May 18th, 2018 2:55 pm
Altimmune Announces First Quarter 2018 Financial Results and Provides Corporate Update - May 15th, 2018 2:01 pm
Who Are The Major Shareholders Of Altimmune Inc (NASDAQ:ALT)? - May 8th, 2018 4:03 pm
Altimmune to Announce First Quarter 2018 Financial Results on May 16 - May 8th, 2018 6:00 am
Free Research Report as ChemoCentryx’s Quarterly Revenues Zoomed More than 1000%; Turned Profitable Y-O-Y - Apr 19th, 2018 5:40 am
Altimmune Announces Financial Results for the Year Ended December 31, 2017 and Provides Corporate Update - Mar 28th, 2018 2:44 pm
Here’s What’s Moving Esperion And Altimmune, Inc. - Mar 28th, 2018 9:10 am
Altimmune Announces Positive Data From Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine and Provides an Update on Its Phase 1b Study of HepTcell Targeted Immunotherapy in Chronic Hepatitis B Infection - Mar 27th, 2018 6:00 am
Should You Be Concerned About Altimmune Inc’s (NASDAQ:ALT) Investors? - Jan 5th, 2018 10:00 am